Join our daily newsletter At The Bell to receive exclusive market insights
- Trajan Group (TRJ) has completed the purchase of LEAP PAL Parts and Consumables
- Earlier this month, the global analytical science and device company said it would purchase LEAP for US$7.7 million (A$10.6 million)
- Trajan CEO Stephen Tomisich said the purchase went to plan and welcomed the team into 2022
- Trajan Group is down 1.02 per cent at $3.90 per share
Trajan Group (TRJ) has completed the purchase of LEAP PAL Parts and Consumables.
Earlier this month, the global analytical science and device company announced it would purchase LEAP for US$7.7 million (A$10.6 million).
LEAP PAL Parts (LPP) has been in the lab instrumentation and liquid handling business for over 25 years.
In 2010 LEAP Technologies spun out its CTC Autosampler small parts and consumables
operation and a new company was born, LEAP PAL Parts and Consumables. LPP carries an extensive array of CTC small parts, valves, rotors and syringes.
LPP has a team of nine staff operating the specialised parts and supplies distribution business, supporting customers operating automated laboratory workflows.
“The completion of the LPP transaction has gone to plan and we welcome the team into the Trajan group as we head into 2022,” Trajan CEO Stephen Tomisich said.
Yesterday, Trajan completed its purchase of California-based blood microsampling devices company, Neoteryx.
The purchase was made through a share swap and cash payment arrangement.
Under the deal, Neoteryx parent company Farrona LLC, was issued over 4 million ordinary fully paid shares in Trajan, along with an additional cash payment of US$5.05 million (nearly A$7 million).
On the market this morning, Trajan Group was down 1.02 per cent to $3.90 per share at 10:35am AEDT.
